{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:15:24Z","timestamp":1790640924076,"version":"4.1.0"},"reference-count":43,"publisher":"National Academy of Sciences","issue":"44","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2013,10,29]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>We have developed a semisynthetic method for the production of bispecific antibody-like therapeutics consisting of a small molecule targeting moiety conjugated to an antibody. A highly selective prostate-specific membrane antigen-binding ligand was site specifically conjugated to a mutant \u03b1 cluster of differentiation 3 (\u03b1CD3) Fab containing an unnatural amino acid with orthogonal chemical reactivity. The optimized conjugate showed potent in vitro activity, good serum half-life, and potent in vivo activity in prostate cancer xenograft mouse models. This semisynthetic approach is likely to be applicable to the generation of additional bispecific agents using drug-like ligands selective for other cell-surface receptors.<\/jats:p>","DOI":"10.1073\/pnas.1316026110","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T20:21:48Z","timestamp":1381782108000},"page":"17796-17801","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":83,"title":["Bispecific small molecule\u2013antibody conjugate targeting prostate cancer"],"prefix":"10.1073","volume":"110","author":[{"given":"Chan Hyuk","family":"Kim","sequence":"first","affiliation":[{"name":"California Institute for Biomedical Research, La Jolla, CA 92037; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Y.","family":"Axup","sequence":"additional","affiliation":[{"name":"Departments of bChemistry,"},{"name":"The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Lawson","sequence":"additional","affiliation":[{"name":"Immunology and Microbial Science, and"},{"name":"California Institute for Biomedical Research, La Jolla, CA 92037; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwayoung","family":"Yun","sequence":"additional","affiliation":[{"name":"Departments of bChemistry,"},{"name":"The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Tardif","sequence":"additional","affiliation":[{"name":"Immunology and Microbial Science, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei Hyun","family":"Choi","sequence":"additional","affiliation":[{"name":"Departments of bChemistry,"},{"name":"The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Departments of bChemistry,"},{"name":"The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dubrovska","sequence":"additional","affiliation":[{"name":"Departments of bChemistry,"},{"name":"The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Biroc","sequence":"additional","affiliation":[{"name":"Ambrx, Inc., La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Marsden","sequence":"additional","affiliation":[{"name":"Ambrx, Inc., La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Pinstaff","sequence":"additional","affiliation":[{"name":"Ambrx, Inc., La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaughn V.","family":"Smider","sequence":"additional","affiliation":[{"name":"Molecular Biology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Schultz","sequence":"additional","affiliation":[{"name":"Departments of bChemistry,"},{"name":"The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037;"},{"name":"California Institute for Biomedical Research, La Jolla, CA 92037; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2013,10,14]]},"reference":[{"key":"e_1_3_3_1_2","volume-title":"Cancer Facts and Figures 2012","author":"American Cancer Society","year":"2012","unstructured":"; American Cancer Society Cancer Facts and Figures 2012 (American Cancer Society, Atlanta, GA, 2012)."},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra021562"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e3182467419"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1722"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-3402"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001294"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0045(19990101)38:1<73::AID-PROS9>3.0.CO;2-V"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3181a697eb"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-0042"},{"key":"e_1_3_3_10_2","first-page":"12","article-title":"Symmetry breaking: Bispecific antibodies, the beginnings, and 50 years on","volume":"12","author":"Riethm\u00fcller G","year":"2012","unstructured":"G Riethm\u00fcller, Symmetry breaking: Bispecific antibodies, the beginnings, and 50 years on. Cancer Immun 12, 12 (2012).","journal-title":"Cancer Immun"},{"key":"e_1_3_3_11_2","first-page":"5522","article-title":"Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer","volume":"60","author":"Dannull J","year":"2000","unstructured":"J Dannull, et al., Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. Cancer Res 60, 5522\u20135528 (2000).","journal-title":"Cancer Res"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0547"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e318195b5bb"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-441030"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.1.6.10015"},{"key":"e_1_3_3_16_2","first-page":"71","article-title":"Chemical production of bispecific antibodies","volume":"283","author":"Graziano RF","year":"2004","unstructured":"RF Graziano, P Guptill, Chemical production of bispecific antibodies. Methods Mol Biol 283, 71\u201385 (2004).","journal-title":"Methods Mol Biol"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja303904e"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp900069d"},{"key":"e_1_3_3_19_2","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver DA","year":"1997","unstructured":"DA Silver, I Pellicer, WR Fair, WD Heston, C Cordon-Cardo, Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 3, 81\u201385 (1997).","journal-title":"Clin Cancer Res"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.09.154"},{"key":"e_1_3_3_21_2","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/pros.21164","article-title":"Saporin toxin-conjugated monoclonal antibody targeting prostate-specific membrane antigen has potent anticancer activity","volume":"70","author":"Kuroda K","year":"2010","unstructured":"K Kuroda, et al., Saporin toxin-conjugated monoclonal antibody targeting prostate-specific membrane antigen has potent anticancer activity. Prostate 70, 1286\u20131294 (2010).","journal-title":"Prostate"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1903"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm801055h"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201204631"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja104591m"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.4049\/jimmunol.155.4.1903","article-title":"Identification of heavy chain residues in a humanized anti-CD3 antibody important for efficient antigen binding and T cell activation","volume":"155","author":"Zhu Z","year":"1995","unstructured":"Z Zhu, P Carter, Identification of heavy chain residues in a humanized anti-CD3 antibody important for efficient antigen binding and T cell activation. J Immunol 155, 1903\u20131910 (1995).","journal-title":"J Immunol"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0234824100"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.1.217"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01392"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi4000244"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja906844e"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2011.01.011"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.10.6112"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0502101102"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.3109\/03602539008991445"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(88)90310-9"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2008.11.014"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3120725"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/11717"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-400515"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri3130"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.1.1.7359"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.384594"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1316026110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T13:47:12Z","timestamp":1716040032000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1316026110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,14]]},"references-count":43,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2013,10,29]]}},"alternative-id":["10.1073\/pnas.1316026110"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1316026110","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,14]]},"assertion":[{"value":"2013-10-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}